Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Starner

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Expression and activity of beta-defensins and LL-37 in the developing human lungTimothy D Starner, Birgitta Agerberth, Gudmundur H Gudmundsson, et al.
Journal of Managed Care Pharmacy : JMCP|June 4, 2010
Pharmacy students' views of managed care pharmacy and PBMS: should there be more exposure to managed care in the pharmacy curriculum?Amy L Pittenger, Catherine I Starner, Kaj Thompson, et al.
Pediatric Pulmonology|November 1, 2016
Implementation of cystic fibrosis clinical pathways improved physician adherence to care guidelinesSachinkumar B Singh, Annie U Shelton, Barbara Greenberg, et al.
Journal of Managed Care & Specialty Pharmacy|June 5, 2023
Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosisLandon Z Marshall, Rachel Espinosa, Catherine I Starner, et al.
Epilepsy & Behavior : E&B|November 21, 2012
Psychogenic nonepileptic seizures and chronic pain: a retrospective case-controlled studyDeana M Gazzola, Chad Carlson, Angela Rugino, et al.
Journal of Managed Care Pharmacy : JMCP|February 7, 2013
Dalfampridine prior authorization program: a cohort studyPatrick P Gleason, Jill Phillips, Beckie A Fenrick, et al.
Pediatric Pulmonology|May 3, 2018
Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patientsBrittany A Bruch, Sachinkumar B Singh, Laura J Ramsey, et al.
The American Journal of Geriatric Pharmacotherapy|March 14, 2009
Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderlyCatherine I Starner, Sheila A Norman, Richard G Reynolds, et al.
Journal of Managed Care Pharmacy : JMCP|August 13, 2008
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning eventsCatherine I Starner, Jeremy A Schafer, Alan H Heaton, et al.
Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Rosiglitazone prior authorization safety policy: a cohort studyCatherine I Starner, Beckie Fenrick, John Coleman, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Expression and activity of beta-defensins and LL-37 in the developing human lungTimothy D Starner, Birgitta Agerberth, Gudmundur H Gudmundsson, et al.
Journal of Managed Care Pharmacy : JMCP|June 4, 2010
Pharmacy students' views of managed care pharmacy and PBMS: should there be more exposure to managed care in the pharmacy curriculum?Amy L Pittenger, Catherine I Starner, Kaj Thompson, et al.
Pediatric Pulmonology|November 1, 2016
Implementation of cystic fibrosis clinical pathways improved physician adherence to care guidelinesSachinkumar B Singh, Annie U Shelton, Barbara Greenberg, et al.
Journal of Managed Care & Specialty Pharmacy|June 5, 2023
Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosisLandon Z Marshall, Rachel Espinosa, Catherine I Starner, et al.
Epilepsy & Behavior : E&B|November 21, 2012
Psychogenic nonepileptic seizures and chronic pain: a retrospective case-controlled studyDeana M Gazzola, Chad Carlson, Angela Rugino, et al.
Journal of Managed Care Pharmacy : JMCP|February 7, 2013
Dalfampridine prior authorization program: a cohort studyPatrick P Gleason, Jill Phillips, Beckie A Fenrick, et al.
Pediatric Pulmonology|May 3, 2018
Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patientsBrittany A Bruch, Sachinkumar B Singh, Laura J Ramsey, et al.
The American Journal of Geriatric Pharmacotherapy|March 14, 2009
Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderlyCatherine I Starner, Sheila A Norman, Richard G Reynolds, et al.
Journal of Managed Care Pharmacy : JMCP|August 13, 2008
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning eventsCatherine I Starner, Jeremy A Schafer, Alan H Heaton, et al.
Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Rosiglitazone prior authorization safety policy: a cohort studyCatherine I Starner, Beckie Fenrick, John Coleman, et al.
Pageof 11